ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Merck and Eisai Ink $5.76B Cancer Deal
biospace
March 09, 2018Merck & Company?and Tokyo-based?Eisai Inc.?have?signed?a strategic collaboration deal to develop and commercialize Lenvima (lenvatinib mesylate) with Merck’s anti-PD-1 drug Keytruda (pembrolizumab).
Pharma Sources Insight January 2025
